LIUZHOU, China, Nov. 14, 2012 /PRNewswire/ -- China BCT Pharmacy Group, Inc., (OTC BB: CNBI), ("China BCT" or the "Company"), a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the three and nine month periods ended September 30, 2012. Third Quarter 2012 Highlights "In the third quarter, the trend of strong pressure on wholesale prices and margins continued," said Mr. Huitian Tang, Chief Executive Officer of the Company. "Government pressure on those margins through a zero profit policy for drug sales by the hospitals, a ceiling on drug price increases during the contract bidding process and a mandate for hospitals to take the lowest bid price in all cases continue. These are the challenges that we are addressing. However we have yet to halt the decline in operating profit from our wholesale activities which has declined 32% for the first nine months of the year and 68% for the third quarter. We have put a great deal of effort into expanding our retail operations to offset the wholesale declines and results are encouraging. Our operating profit from our retail activities is up 10% for the year so far, although expansion … Continue reading →

DGAP-News: Celesio AG / Key word(s): Disposal Celesio AG: Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar 14.11.2012 / 07:00 Celesio sells Irish pharmaceutical wholesale subsidiary to Uniphar * Divestment programme concluded faster than planned Stuttgart, Germany / Dublin, Ireland, 14 November 2012. Celesio sells its Irish pharmaceutical wholesale subsidiary Cahill May Roberts Ltd (including Movianto Ireland) to Uniphar, an Irish pharmaceutical wholesale and logistics company, headquartered in Dublin. The sales price amounts to 49.9 million euro. The transaction is subject to the approval of the relevant bodies. Celesio CEO Markus Pinger: We will now focus on the Irish pharmacy sector. With more than 70 pharmacies we have a strong market position which offers us good growth opportunities.Therefore, the sale of our Irish wholesale subsidiary was a logical consequence. At the same time, we have thus successfully concluded our divestment programme, faster than planned. We will now focus even more on the future growth projects in context with our strategic realignment. In addition to Cahill May Roberts, Celesios divestment programme, which was started in 2012, included the already completed sales of Movianto (excluding Movianto Ireland), Pharmexx, the mail-order pharmacy DocMorris as well as the activities in the Czech Republic. Press … Continue reading →

HANGZHOU, China--(BUSINESS WIRE)-- China Jo-Jo Drugstores, Inc. (CJJD), (the "Company"), a retail and wholesale distributor of pharmaceutical and other healthcare products in Zhejiang and Shanghai, today reported earnings results for the second quarter of fiscal 2013 ended September 30, 2012. The Company will hold its second quarter fiscal 2013 earnings call on Friday, November 16, 2011 at 8:00 a.m. Eastern Time. Please see below for dial in information. Second Quarter Highlights: Dr. Lei Liu, Chairman and CEO, stated, "Given Chinas slower economic and increased regulatory environment towards retail pharmacies, we are pleased that we continue to make progress to better vertically integrate our operations. Our wholesale business has continued to grow and will give us the foothold we need to establish our long-term position." Since August 2011, stricter government policies towards the marketing practices of retail drugstores, industry competition and further government drug price control have impacted sales at our retail drugstores. However, as more of our drugstores are approved to accept government medical insurance, the Company's retail drugstores sales revenue improved to $9,637,418 during the three months ended September 30, 2012 over revenue of $8,393,098 during the three months ended June 30, 2012. Dr. Liu further commented, "Looking forward, … Continue reading →